Oxford Biomedica plc (OXB.L) LSE

Currency In GBp

AD

Valuation

Market Cap690.56M
Enterprise Value741.8M
P/E Ratio-19.61
PEG Ratio-0.57
Price/Sales Ratio4.02
Price/Book Ratio6.49
Enterprise/Revenue4.32
Enterprise/EBITDA-79.93

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.18
Operating Margin-0.18
AD

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.49

Income Statement

Revenue168.74M
Revenue/Share1.59
Gross Profit65.98M
EBITDA-9.12M
Net Income-30.13M
Diluted EPS-0.27

Balance Sheet

Total Cash96.88M
Total Cash/Share0.92
Total Debt148.13M
Total Debt/Equity1.62
Current Ratio2.2
Book Value Per Share0.86

Price History

52-Week Change21.08
52-Week High962
52-Week Low423.5
Moving Average 50 Days608.66
Moving Average 200 Days649.61

Statistics

Average Volume371,186
Shares Outstanding121.04M
% Held by Institutions3.14

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 30, 2018
AD